Synopsys (Synopsys) Change In Working Capital : $-667 Mil (TTM As of Jan. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Synopsys Change In Working Capital?

Synopsys's change in working capital for the quarter that ended in Jan. 2024 was $-671 Mil.

Synopsys's change in working capital for the fiscal year that ended in Oct. 2023 was $-327 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Synopsys Change In Working Capital Historical Data

The historical data trend for Synopsys's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synopsys Change In Working Capital Chart

Synopsys Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Working Capital

Get a 7-Day Free Trial

-75.29

-188.46

130.18

-59.34

-327.34

Synopsys Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Working Capital	Get a 7-Day Free Trial															-330.89	241.92	3.72	-242.09	-670.50

Synopsys Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-667 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Synopsys Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Synopsys's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Synopsys (Synopsys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

SNPS:Mexico SYPd:UK SYP:Germany SYP:Germany SYP:Germany S1NP34:Brazil

Address

675 Almanor Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.synopsys.com

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Executives

Mercedes Johnson	director	MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Richard S. Mahoney	officer: Chief Revenue Officer	2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr	officer: General Counsel &	C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Sudhindra Kankanwadi	officer: VP and Corporate Controller	690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter	director	C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Geus Aart De	director, officer: Chairman of the Board & Co-CEO
Sassine Ghazi	officer: Chief Operating Officer	3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Shelagh Glaser	officer: CFO	ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Roy Vallee	director	2211 S 47TH ST, PHOENIX AZ 85034
Joseph W Logan	officer: EVP, Sales & Corp Marketing	700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias	director	UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham	officer: CFO	700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen	director	58 SUNSET RIDGE LANE, BOLTON MA 01740
Marc N Casper	director	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Chi-foon Chan	director, officer: Co-CEO & President